InsidersTradesSigma
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the detailed record of transactions filed by Derakhshan Behrad. Officer active across 1 company, notably Edgewise Therapeutics, Inc.. Cumulatively, 13 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €194k. History available since 1 May 2023. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 de 13 declaraciones
Derakhshan Behrad is a declarant linked to Edgewise Therapeutics, Inc. (XNAS), where the listed role is Chief Business Officer. The 6 total filings recorded cover the period from 2023-05-03 to 2025-05-07; across the 6 sampled filings, the most frequent transaction nature is Levée d'options, with sum_buy_eur at 0 and sum_sell_eur at 0.